Selegiline less effective than levodopa, dopamine agonists: meta-analysis


A Cochrane meta-analysis has concluded that monoamine oxidase (MAO)-B inhibitors are a treatment option in early PD patients but appear to be somewhat less effective than levodopa or a dopamine agonist (Caslake et al. Cochrane Database Syst Rev 2009; Oct 7;(4): CD006661).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page